webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Mal-PEG4-bis-PEG4-propargyl

  CAS No.:   Cat No.: BADC-01276   Purity: ≥95% 4.5  

Mal-PEG4-bis-PEG4-propargyl is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

Mal-PEG4-bis-PEG4-propargyl

Structure of

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C49H81N5O20
Molecular Weight
1060.19
Shipping
Room temperature
Shipping
Store at -5°C,keep in dry and avoid sunlight.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Solubility
10 mm in DMSO
Shelf Life
0-4°C for short term (days to weeks), or -20°C for long term (months).
Shipping
Room temperature
Storage
Store at -5°C,keep in dry and avoid sunlight.

Mal-PEG4-bis-PEG4-propargyl is a versatile compound used primarily in bioconjugation and targeted drug delivery applications. The maleimide (Mal) group allows for the selective conjugation to thiol-containing biomolecules such as proteins, antibodies, or peptides, enabling the creation of targeted drug delivery systems. The PEG4 spacers enhance the solubility, stability, and pharmacokinetics of the conjugate, ensuring that the payload remains soluble and protected in vivo. The propargyl group enables bioorthogonal reactions with azide-functionalized molecules through the copper-catalyzed azide-alkyne cycloaddition (CuAAC) reaction, a widely used strategy for selective conjugation and activation in complex biological environments. This feature is particularly useful for targeted therapy and imaging applications.

One of the key applications of Mal-PEG4-bis-PEG4-propargyl is in the development of antibody-drug conjugates (ADCs) for cancer treatment. By using the maleimide group to link cytotoxic agents to monoclonal antibodies, this conjugate allows for selective targeting of tumor cells that express specific surface antigens. The PEG4 spacers improve the pharmacokinetics of the conjugate, increasing its solubility and circulation time. The propargyl group facilitates the precise attachment of additional therapeutic or diagnostic agents using the CuAAC reaction, allowing for multivalent targeting or the incorporation of imaging agents for monitoring therapeutic efficacy. This targeted approach enhances the specificity and potency of chemotherapy while minimizing side effects.

Mal-PEG4-bis-PEG4-propargyl is also used in bioorthogonal chemistry for selective labeling and imaging of biomolecules. The propargyl group reacts with azide-containing molecules in living systems via CuAAC, making it an ideal tool for the covalent labeling of proteins, nucleic acids, or other biomolecules. This allows researchers to track the behavior and interactions of specific molecules in vivo, providing valuable insights into cellular processes and molecular pathways. The PEG4 linkers ensure that the conjugated molecules remain soluble, stable, and functional, which is crucial for accurate labeling and imaging in complex biological environments. This application is particularly beneficial in molecular imaging, proteomics, and cellular biology research.

Additionally, Mal-PEG4-bis-PEG4-propargyl is used in the design of drug delivery systems that require controlled release. The maleimide group enables stable conjugation with therapeutic agents, while the PEG4 spacers improve the pharmacokinetics and bioavailability of the drug. The propargyl group provides a site for the attachment of other bioactive molecules or targeting ligands using CuAAC, enabling the creation of multi-functional delivery systems. These systems can be designed to release drugs at specific sites in response to a variety of stimuli, such as changes in pH or the presence of specific enzymes, enhancing the selectivity and efficacy of the treatment. This approach is particularly promising in the context of personalized medicine and targeted therapy.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Bis(NHS)PEG5 | Alkyne-PEG4-SS-PEG4-alkyne | DXD | Tetrazine-SS-NHS | Mal-PEG2-acid | Mertansine | Fmoc-Val-Ala-Gly-OH | Trastuzumab duocarmazine | LK-66 M | Gly3-VC-PAB-MMAE | Mal-PEG4-bis-PEG4-propargyl
Send Inquiry
Verification code
Inquiry Basket